Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athenix CorporationfiledCriticalAthenix Corporation
Publication of RS51812BpublicationCriticalpatent/RS51812B/en
Molekul nukleinske kiseline izdvojen iz grupe, koja se sastoji od:a) molekula nukleinske kiseline koji sadrži nukleotidnu sekvencu SEQ ID NO: 28, 30, 32 ili 34; ib) molekula nukleinske kiseline koji kodira polipeptid koji sadrži aminokiselinsku sekvencu SEQ ID NO: 29, 31, 33 ili 35.Prijava sadrži još 14 patentnih zahteva.A nucleic acid molecule isolated from the group consisting of: a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 28, 30, 32 or 34; and (b) a nucleic acid molecule encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 29, 31, 33 or 35. The application contains 14 more claims.
RS20110347A2006-11-292007-11-20Improved grg23 epsp synthases: compositions and methods of use
RS51812B
(en)